FindTrial
Sign In

Molecular Characterization Study of EBV-Negative Nasopharyngeal Carcinoma

Molecular Characterization Study of EBV-Negative Nasopharyngeal Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112719
Enrollment
Unknown
Registered
2025-11-18
Start date
2015-06-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EBV-negative nasopharyngeal carcinoma

Interventions

Observation group:NA

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.A patient diagnosed with EBV-negative nasopharyngeal carcinoma upon initial hospital admission. 2.A patient with comprehensive blood sample data, as well as pathology specimens from both the primary and metastatic lesions, available at our hospital.

Exclusion criteria

Exclusion criteria: 1.Patients who do not meet the diagnostic criteria for EBV-negative nasopharyngeal carcinoma. 2.Patients with multiple cancers. 3.Patients with missing lesion specimen data.

Design outcomes

Primary

MeasureTime frame
mutation;—

Countries

China

Contacts

Public ContactMusheng zeng

Sun Yat-sen University Cancer Center

zengmsh@sysucc.org.cn+86 20 8734 3191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026